CMP-5 hydrochloride is a potent and selective PRMT5 inhibitor that blocks EBV-driven B-lymphocyte transformation without affecting normal B cells; it selectively inhibits PRMT5 methyltransferase activity, thereby blocking S2Me-H4R3 during histone preparation.